Showing 5 Abstracts.
02 : 00 PM
4-Phenylbutyric Acid Reduces Endoplasmic Reticulum Retention and Partially Restores Function of LDLR p.D622N Mutation In Vitro: A Potential Therapy for Hypercholesterolemia
Wang Yongxiang, Zhang Piyi, Bai Ming, Zhang Zheng
Final Pr. ID: Sa1098
Authors: Wang Yongxiang , Zhang Piyi , Bai Ming , Zhang Zheng
Keywords: Hyperlipoproteinemia, Gene mutations, Family, Cholesterol-lowering drugs, Genetics
09 : 00 AM
Greater Long-Term Non-High Density Lipoprotein Cholesterol Variability From Childhood Is Associated With Higher Risk Of Early-Onset Hypertension: The Bogalusa Heart Study
Kang Soo Jung, Gill Eunsun, Hwang Phillip, De Anda-duran Ileana, Jin Xuanyi, Fern?ndez Alonso Camilo, Bazzano Lydia
Final Pr. ID: P-372
Authors: Kang Soo Jung , Gill Eunsun , Hwang Phillip , De Anda-duran Ileana , Jin Xuanyi , Fern?ndez Alonso Camilo , Bazzano Lydia
Keywords: Hypertension, Hyperlipoproteinemia, Atherosclerosis
11 : 13 AM
Impact of Lipoprotein(a) on Aortic Valve Replacement in Chinese Patients with Mild-to-Moderate Calcific Aortic Valve Stenosis
Lu Mengying, Wang Xiao, Dou Kefei, Wu Naqiong, Li Zhi Fan, Yin Zheng, Li Xi, Zhang Wenjia, Luo Fang, Liu Xiaoning, Xu Yanlu, Liu Chen
Final Pr. ID: MP2542
Authors: Lu Mengying , Wang Xiao , Dou Kefei , Wu Naqiong , Li Zhi Fan , Yin Zheng , Li Xi , Zhang Wenjia , Luo Fang , Liu Xiaoning , Xu Yanlu , Liu Chen
Keywords: Aortic valve stenosis, Lipoproteins, Calcification, Hyperlipoproteinemia, Prognosis
11 : 20 AM
Olpasiran Outperforms Other Subcutaneous Lipoprotein(a)-Lowering Agents in Efficacy and Safety: A Network Meta-Analysis of Randomized Controlled Trials
Tanriverdi Lokman H., Dogan Muhammed Melih, Su Angela, Shan Ryan, Banach Maciej, Hernandez Adrian V.
Final Pr. ID: MP2753
Authors: Tanriverdi Lokman H. , Dogan Muhammed Melih , Su Angela , Shan Ryan , Banach Maciej , Hernandez Adrian V.
Keywords: Atherosclerosis, Lipoproteins, Pharmacology, Evidence-based medicine, Hyperlipoproteinemia
01 : 45 PM
Overcoming Barriers For Research Participation In Minority Patients In Lp(a)FRONTIERS EXPANSION: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate Efficacy And Safety Of Pelacarsen In U.S. Black And Hispanic Patients with Elevated Lp(a) And Established ASCVD
Ferdinand Keith, Rodriguez Fatima, Amraotkar Alok, Venkataraman Subha, Ayaz Imran, Antequera Oliver, Cao Hui, Zhu Wenyue, Shapiro Michael
Final Pr. ID: MP913
Authors: Ferdinand Keith , Rodriguez Fatima , Amraotkar Alok , Venkataraman Subha , Ayaz Imran , Antequera Oliver , Cao Hui , Zhu Wenyue , Shapiro Michael
Keywords: Lipoproteins, Disparities, Cardiovascular disease, Hyperlipoproteinemia, Race